Literature DB >> 11792630

Core 2 oligosaccharides mediate eosinophil and neutrophil peritoneal but not lung recruitment.

David H Broide1, Marina Miller, Diego Castaneda, Jyothi Nayar, Jae Youn Cho, Mark Roman, Lesley G Ellies, P Sriramarao.   

Abstract

We have investigated the importance of cell-surface serine- and/or threonine-linked oligosaccharide adhesion molecules synthesized by the Golgi enzyme core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GlcNAcT) in mediating eosinophil trafficking to the lung in studies utilizing C2GlcNAcT-I-deficient mice. The number of bronchoalveolar eosinophils, the number of lung eosinophils, and airway responsiveness to methacholine were not significantly different in C2GlcNAcT-I-deficient compared with wild-type mice sensitized and challenged by inhalation with ovalbumin. C2GlcNAcT-I-deficient mice do not demonstrate defects in neutrophil trafficking to the lung in response to lipopolysaccharide (LPS). In contrast, ragweed-sensitized C2GlcNAcT-I-deficient mice exhibit significantly reduced eosinophil trafficking to the peritoneal cavity in response to ragweed peritoneal challenge. C2GlcNAcT-I-deficient mice also have significantly reduced neutrophil trafficking to the peritoneal cavity in response to LPS challenge. Overall, these studies demonstrate an important role for serine/threonine-linked oligosaccharides synthesized by the Golgi enzyme C2GlcNAcT-I in eosinophil and neutrophil trafficking to the peritoneum but not for eosinophil or neutrophil trafficking to the lung.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792630     DOI: 10.1152/ajplung.00214.2001

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

Review 1.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 2.  Mucin-type O-glycosylation during development.

Authors:  Duy T Tran; Kelly G Ten Hagen
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

3.  Mucin O-glycan branching enzymes: structure, function, and gene regulation.

Authors:  Pi-Wan Cheng; Prakash Radhakrishnan
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

4.  N-Glycans differentially regulate eosinophil and neutrophil recruitment during allergic airway inflammation.

Authors:  Nooshin S Bahaie; Bit Na Kang; Elizabeth M Frenzel; M Reza Hosseinkhani; Xiao Na Ge; Yana Greenberg; Sung Gil Ha; Michael Demetriou; Savita P Rao; P Sriramarao
Journal:  J Biol Chem       Date:  2011-09-12       Impact factor: 5.157

Review 5.  Pathobiology of neutrophil-epithelial interactions.

Authors:  Jennifer C Brazil; Charles A Parkos
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

Review 6.  Recent insights into the biological roles of mucin-type O-glycosylation.

Authors:  E Tian; Kelly G Ten Hagen
Journal:  Glycoconj J       Date:  2008-08-10       Impact factor: 2.916

7.  Core2 1-6-N-glucosaminyltransferase-I is crucial for the formation of atherosclerotic lesions in apolipoprotein E-deficient mice.

Authors:  Huan Wang; Rong Tang; Weiyu Zhang; Karine Amirikian; Zhen Geng; Jianguo Geng; Robert P Hebbel; Lijun Xia; Jamey D Marth; Minoru Fukuda; Shigeki Katoh; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-04       Impact factor: 8.311

8.  Deficiency in the glycosyltransferase Gcnt1 increases susceptibility to tuberculosis through a mechanism involving neutrophils.

Authors:  Kaori L Fonseca; Ana Raquel Maceiras; Rita Matos; Luisa Simoes-Costa; Jeremy Sousa; Baltazar Cá; Leandro Barros; Ana Isabel Fernandes; Stefan Mereiter; Ricardo Reis; Joana Gomes; Gustavo Tapia; Paula Rodríguez-Martínez; Montse Martín-Céspedes; Sergo Vashakidze; Shota Gogishvili; Keti Nikolaishvili; Rui Appelberg; Fátima Gärtner; Pedro N S Rodrigues; Cristina Vilaplana; Celso A Reis; Ana Magalhães; Margarida Saraiva
Journal:  Mucosal Immunol       Date:  2020-03-13       Impact factor: 7.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.